# Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use

> **NCT03274999** · NA · TERMINATED · sponsor: **Allergan** · enrollment: 10 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DEVICE:** TrueTear™ Application

## Key facts

- **NCT ID:** NCT03274999
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-18
- **Primary completion:** 2017-11-09
- **Final completion:** 2017-11-09
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Based on interim review and decision to re-design the study.
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03274999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03274999, "Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03274999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*